AMPH R&D to Revenue
Amphastar Pharmaceuticals Inc · R&D to Revenue
AMPH R&D to Revenue
Latest reported12.05%period ending
AMPH Quarterly R&D/Revenue (16.79% → 12.05%)
Latest values, visible window
High-resolution chart · PNG
AMPH r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.052% | |
| 15.6201% | |
| 12.7326% | |
| 11.6524% | |
| 11.5128% | |
| 11.7846% | |
| 9.7264% | |
| 11.1625% | |
| 9.6779% | |
| 8.2829% | |
| 11.4646% | |
| 9.2293% | |
| 11.5591% | |
| 14.1513% | |
| 12.7652% | |
| 15.4118% | |
| 18.4649% | |
| 13.4778% | |
| 14.2993% | |
| 9.5893% | |
| 17.8256% | |
| 14.3322% | |
| 18.9041% | |
| 21.148% | |
| 18.8204% | |
| 18.0699% | |
| 23.5588% | |
| 23.2177% | |
| 20.2361% | |
| 18.3068% | |
| 18.6576% | |
| 15.0113% | |
| 21.7736% | |
| 24.4207% | |
| 18.862% | |
| 17.3355% | |
| 16.4634% | |
| 19.8518% | |
| 19.3208% | |
| 15.1394% | |
| 15.4043% | |
| 14.1293% | |
| 11.2518% | |
| 17.4062% | |
| 19.9172% | |
| 11.5459% | |
| 13.6711% | |
| 14.3776% | |
| 12.2319% | |
| 13.5361% | |
| 13.2717% | |
| 15.2416% | |
| 12.4608% | |
| 16.8117% | |
| 16.7877% |